BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7793318)

  • 21. [Infectious risk factors in the development of malignant neoplasms].
    Shevliagin VIa; Borodina NP; Snegireva AE; Shaposhnikova GM
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):40-2. PubMed ID: 9381869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
    Suchman EL; Pattengale PK; Fan H
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental models and conceptual approaches to studies of lymphomas and leukemia: etiology, biology, and control.
    Ihle JN
    Semin Hematol; 1978 Apr; 15(2):95-115. PubMed ID: 206975
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of the components of Bordetella pertussis lipopolysaccharides on Rauscher virus-induced leukosis in mice].
    Shaposhnikova GM; Chetina EV; Snegireva AE; Borodina NP; Lapaeva IA; Shevliagin VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):18-9. PubMed ID: 7879511
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylactic intervention in RadLV-induced lymphomagenesis with an anti-IL-4 monoclonal antibody.
    Epzsteyn S; Vitetta ES; Yefenof E
    J Immunother; 1997 Jul; 20(4):287-91. PubMed ID: 9220318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Infectious properties of the N-tropic virus OA-3 isolated from the BALB/3T3 cell line].
    Iakovleva LS; Seniuta NB; Shcherbak LN; Pavlish OA; Shcherbak NP
    Vopr Virusol; 1988; 33(5):614-7. PubMed ID: 3218217
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental infection of cynomolgus monkeys with a human retrovirus, adult T-cell leukemia virus.
    Yamamoto N; Hayami M; Komuro A; Schneider J; Hunsmann G; Okada M; Hinuma Y
    Med Microbiol Immunol; 1984; 173(1):57-64. PubMed ID: 6088962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector.
    Kitagawa M; Aizawa S; Kamisaku H; Hirokawa K; Ikeda H
    Exp Hematol; 1999 Feb; 27(2):234-41. PubMed ID: 10029162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal dominance of RadLV-induced lymphomas.
    Avni O; Yefenof E; Kotler M
    Leuk Res; 1995 Dec; 19(12):971-6. PubMed ID: 8632667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of growth hormone on Gross passage A virus-induced thymus leukemia in C3Hf mice.
    Duquesnoy RJ; Pedersen GM
    Cancer Res; 1979 Feb; 39(2 Pt 1):415-8. PubMed ID: 761214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of immune protection after vaccination with attenuated live murine leukemia virus.
    Ruprecht RM; Hu Y; Liska V; Rasmussen R; Sharma P
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):375-7. PubMed ID: 8882313
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.
    Peterson KE; Stromnes I; Messer R; Hasenkrug K; Chesebro B
    J Virol; 2002 Aug; 76(16):7942-8. PubMed ID: 12133998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic retroviruses of cattle, chickens and turkeys: potential infectivity and oncogenicity for humans.
    Johnson ES; Griswold CM
    Med Hypotheses; 1996 Apr; 46(4):354-6. PubMed ID: 8733164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of experimental feline leukemia virus infection.
    Rojko JL; Hoover EA; Mathes LE; Olsen RG; Schaller JP
    J Natl Cancer Inst; 1979 Sep; 63(3):759-68. PubMed ID: 224237
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cholinergic mechanisms in the development of cytopenia as a preleukemic syndrome (the problems of pathogenesis, diagnosis and therapy)].
    Savina LS; Martynova VA; Savin AG
    Voen Med Zh; 1989 Jul; (7):38-42. PubMed ID: 2683369
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunizing and interfering action of non-leukemogenic C-type murine virus variants in leukemogenesis.
    Barski G; Youn JK
    Bibl Haematol; 1973; 39():370-6. PubMed ID: 4360168
    [No Abstract]   [Full Text] [Related]  

  • 37. Viral genes involved in leukemogenesis. I. Generation of recombinants between oncogenic and nononcogenic mouse type-C viruses in tissue culture.
    Aaronson SA; Barbacid M
    J Exp Med; 1980 Feb; 151(2):467-80. PubMed ID: 6153214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced induction of growth of B lymphoblasts from fresh human blood by primate type-C retroviruses (gibbon ape leukemia virus and simian sarcoma virus).
    Markham PD; Ruscetti F; Salahuddin SZ; Gallagher RE; Gallo RC
    Int J Cancer; 1979 Feb; 23(2):148-56. PubMed ID: 216638
    [No Abstract]   [Full Text] [Related]  

  • 39. Type-C RNA virus and leukemogenesis: lack of correlation between expression of endogenous, ecotropic murine leukemia virus and radiation leukemogenesis in mice.
    Nagao K
    Hiroshima J Med Sci; 1977 Sep; 26(2-3):177-88. PubMed ID: 201595
    [No Abstract]   [Full Text] [Related]  

  • 40. At least four non-env factors that reside in the LTR, in the 5'-non-coding region, in gag and in part of pol affect neuropathogenicity of PVC-441 murine leukemia virus (MuLV).
    Tanaka A; Saida K; Andoh M; Maeda K; Kai K
    Virus Res; 2000 Aug; 69(1):17-30. PubMed ID: 10989182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.